- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Brentuximab vedotin – March 2014
Brentuximab Vedotin, 50 mg injection, 1 x 50 mg vial Adcetris®
Last updated
8 November 2023